Drug intelligence / Profile preview

Atzirut X

Development stage
Unknown
Lead developer
CTS Chemical Industries
Modality
Small Molecules
Administration
Oral
01

Overview

Atzirut X is a botanical stimulant laxative product developed and marketed by the Israeli pharmaceutical company CTS. It is indicated for the short-term relief of occasional constipation. The formulation is a combination of two plant extracts: Senna (*Cassia angustifolia*) and Buckthorn (*Rhamnus frangula*). These extracts contain anthraquinone glycosides, such as sennosides and glucofrangulins, which act as prodrugs. Upon reaching the colon, they are hydrolyzed by bacterial enzymes into active metabolites like rheinanthrone. These metabolites stimulate the myenteric plexus (Auerbach's plexus) to increase intestinal peristalsis and inhibit the Na+/K+-ATPase pump in the intestinal wall, which reduces water and electrolyte absorption and promotes fluid secretion into the lumen. The combined effect softens the stool and facilitates bowel evacuation. Atzirut X is registered as an over-the-counter (OTC) pharmaceutical drug in Israel.

Brand names
Atzirut XAtzirut-X
Other names
Atzirut X TabletsAtzirut X Tea
02

Targets

ATP1A (Sodium/potassium-transporting ATPase)

Beyond the preview

Go deeper on Atzirut X.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atzirut X.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call